National Institute of Virology Pune develops first indigenous COVID-19 test kit

National Institute of Virology Pune develops first indigenous antibody detection kit for COVID-19, ELISA

Kohima, May 11 (NE): The Union Health Minister, Dr. Harsh Vardhan on Sunday, May 10, announced that National Institute of Virology, Pune, has successfully developed the first indigenous antibody detection kit for COVID-19, ELISA.

Taking to twitter, the Union Health Minister said that the ‘National Institute of Virology, Pune has successfully developed the 1st indigenous anti-SARS-CoV-2 human IgG ELISA test kit for antibody detection of COVID19’.

This robust test will play a critical role in surveillance of proportion of population exposed to SARSCoV2 infection, tweets Union Minister.

ELISA has the advantage of testing 90 samples together in a single run of 2.5 hours, so that healthcare professionals can proceed quickly with necessary next steps on their patients’ triage paths.

This kit was validated at 2 sites in Mumbai, it has high sensitivity and accuracy. ELISA based testing is easily possible even at district level, he added.

The Drug Controller General has granted commercial production and marketing permission to Zydus. The ICMR National Institute of Virology Pune technology has been transferred to Zydus for mass-scale production.’ he added.

ELISA based testing is cost effective, sensitive, rapid and a large number of samples can be tested at any level of clinical settings, public health care and hospitals, stated Union Minister.

India recorded the biggest single-day jump in the number of Coronavirus patients with 4,213 new cases in the last 24 hours and 97 deaths, which takes the total to 67,152 cases so far, Union Health Ministry said.